Verve Therapeutics, Inc.: Positive Opinion of Guggenheim







Marketzone with MT Newswires 2022

All the news about VERVE THERAPEUTICS, INC.

Analyst Recommendations for VERVE THERAPEUTICS, INC.

2022 turnover

2022 net result -132M

-129M
trso. net 2022 206M

201M
PER 2022-11.7x
2022 return
Capitalization 1,745M
1,745M
1,709M
VE / CA 2022
VE / CA 2023
Number of employees113
Floating64.9%

Chart VERVE THERAPEUTICS, INC.


Hard :

Period:




Verve Therapeutics, Inc.: Verve Therapeutics, Inc. Technical Analysis Chart |  Market area

Trends Technical Analysis VERVE THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsbullishbullishBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts8
Last Closing Price$30.61
Average price target$51.57
Deviation / Average Target68.5%

Officers and Directors




Source link -88